HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.
about
Pathogenesis of human immunodeficiency virus infectionTwin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitroClinical significance of HIV-1 coreceptor usage.Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agentsPresence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapyPathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu miceCharacterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient.The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C virusesHIV-1 Transmission, Replication Fitness and Disease Progression.Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmiEvolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infectionChemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis.Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virusDetection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisHIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism.No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads.Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants.Back to the future: covalent epitope-based HIV vaccine development.HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppressionIn vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell declineSelective transmission of R5 HIV-1 variants: where is the gatekeeper?MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infectionDifferential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine.Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine seraSequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1
P2860
Q24634681-8BFD98A0-7658-4A1A-B932-A7BEDF01EDA0Q27480750-0473376A-BD1E-4291-9279-56C18C2244F9Q27691426-4EE50E47-DE01-4C6E-800D-16A795B0A5B2Q28378547-DEDE5033-F254-417C-BB3A-2E427E8A4F47Q29615993-2E455EB4-7D11-4262-AEA6-C80B277E9B48Q30305455-5410733B-CBF0-497B-90A3-AC81F5689D34Q30322838-35993429-3F8B-4C33-BA0D-A6A4C51815EEQ33318083-2A2537F6-48B5-49A4-B9FF-3136FB6B336EQ33641854-F3691FDB-A771-4484-AD57-8A4BA4FADA14Q33719811-7E47B69D-16DC-401D-8EED-5D122CA728D5Q33736978-3FE01538-BA27-496F-9954-1888D2C46773Q33758570-85F1C586-930C-46E2-BBA0-BD40F1479091Q33781934-9D3F16A9-D54D-4284-A69A-EF0D7CC6A9D3Q33784321-EAA3F569-A11A-4BB9-AAC4-D2E3B7C1A97BQ33785137-E075AF7B-C363-4515-8482-47087FB16289Q33785473-FC19B303-3D9D-48D6-B6A7-CADDDFF3EFFCQ33786386-F15413E3-8AFE-45F4-9103-FAAD30148BA4Q33813025-954F37D6-1583-43F9-9AC0-FB2B428B9D61Q33816465-4040CD08-DD45-44CD-B255-D1608CF39157Q33842020-24B8B722-8F3D-4AA7-B84C-EBDF9A037698Q33951977-05CCD6D9-518E-4904-AA0B-81D432095F94Q33968924-8EC4519E-C703-4A97-9B50-F91EEE5DCC50Q34010283-F1655189-35E1-4F41-A30C-040E9861E2C2Q34193190-4DFF1C9B-1391-4665-9087-6DC107794E3DQ34220902-D1C4C8A9-913B-4BD6-A3FB-9793E7918B7CQ34316588-7A3C0279-1E1A-4E7F-8001-BABB8EE9E562Q34342452-AFD45571-AEA0-4AC3-A65B-A7E2E7FC0CCDQ34597300-2A5D5ACD-971B-416C-A23A-48E06996C08FQ34923915-105D92D1-CE61-4FBE-87D4-292B53948332Q34949513-A24C6BFC-1910-42A2-AD2E-CE1CE03E7F4DQ35009308-CA01116C-1D64-43B8-AA21-B76DF9F63265Q35015256-D6098D56-A003-4AAC-80FF-9F6473CCB9C5Q35018140-8AD33617-EDAA-4C06-8961-D73701B3B19EQ35124100-74CB81E8-149D-4CE9-8323-21DB2D32BD12Q35127334-295B502C-1476-4C4F-84EB-21CFE8A3B7B5Q35133895-075486D9-AAF3-4F7E-B918-9332EDFBB172Q35198556-B3A98A0A-1C71-4859-A252-9495BBED8D47Q35828529-C6E7A690-F531-4D10-855A-82A5ED22FB11Q35838430-8ACE5C93-C2B6-4E43-8D77-874930FF6691Q35839969-5E9A7CAA-3EFC-462A-A4D9-6A5744F6610E
P2860
HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.
@en
type
label
HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.
@en
prefLabel
HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.
@en
P2093
P1433
P1476
HIV-1 biological phenotype in ...... h an MT-2 cocultivation assay.
@en
P2093
Coutinho RA
Dercksen MW
Terpstra FG
Tersmette M
de Goede RE
P407
P577
1992-01-01T00:00:00Z